Recent QSI News
- Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/14/2026 12:00:00 AM
- Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones • Business Wire • 05/07/2026 08:05:00 PM
- Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ • Business Wire • 05/01/2026 12:30:00 PM
- Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments • Business Wire • 04/28/2026 12:30:00 PM
- Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026 • Business Wire • 04/16/2026 12:30:00 PM
- Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting • Business Wire • 04/15/2026 12:30:00 PM
- Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies • Business Wire • 04/14/2026 12:30:00 PM
- Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/10/2026 09:30:00 PM
- Quantum-Si Announces First Customer Samples Tested on the Proteus™ Prototype System • Business Wire • 04/08/2026 01:15:00 PM
- Quantum-Si Announces the Start of the Proteus™ Roadshow • Business Wire • 04/06/2026 01:40:00 PM
- Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/13/2026 08:05:00 PM
- Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results • Business Wire • 03/03/2026 09:05:00 PM
- Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 02/13/2026 09:05:00 PM
- Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 • Business Wire • 02/10/2026 01:00:00 PM
- Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection • Business Wire • 02/05/2026 01:00:00 PM
- Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements • Business Wire • 12/22/2025 01:00:00 PM
- Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 12/15/2025 11:00:00 PM
- Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day • Business Wire • 11/20/2025 01:00:00 PM
- Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company’s Industry Leading Technology Pipeline at Investor & Analyst Day • Business Wire • 11/19/2025 01:00:00 PM
- Quantum-Si Reports Third Quarter 2025 Financial Results • Business Wire • 11/05/2025 09:05:00 PM
- Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum • Business Wire • 10/20/2025 12:00:00 PM
- Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025 • Business Wire • 10/13/2025 12:00:00 PM
- Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025 • Business Wire • 09/23/2025 12:00:00 PM
- Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/15/2025 08:05:00 PM
- Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing • Business Wire • 09/08/2025 12:00:00 PM
